REPORT ID 3791

EMEA (Europe, Middle East and Africa) Human Growth Hormone Market Report 2017

Publish Date
14-Dec-17
Pages
118
Format
Electronic (PDF)

In this report, the EMEA Human Growth Hormone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Human Growth Hormone for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Growth Hormone market competition by top manufacturers/players, with Human Growth Hormone sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Novo Nordisk
    Pfizer
    Eli Lilly
    Merck Serono
    F. Hoffmann-La Roche
    Ferring Pharmaceuticals
    GeneScience Pharmaceuticals
    Ipsen
    LG Life Sciences
    Sandoz International
    Anhui Anke Biotechnology

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Powder
    Solvent

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Growth Hormone Deficiency (GHD)
    Turner Syndrome
    Chronic Renal Insufficiency
    Prader Willi Syndrome
    Small for Gestational Age
    SHOX Deficiency
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Human Growth Hormone Market Report 2017
1 Human Growth Hormone Overview
    1.1 Product Overview and Scope of Human Growth Hormone
    1.2 Classification of Human Growth Hormone
        1.2.1 EMEA Human Growth Hormone Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Human Growth Hormone Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Powder
        1.2.4 Solvent
    1.3 EMEA Human Growth Hormone Market by Application/End Users
        1.3.1 EMEA Human Growth Hormone Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Growth Hormone Deficiency (GHD)
        1.3.3 Turner Syndrome
        1.3.4 Chronic Renal Insufficiency
        1.3.5 Prader Willi Syndrome
        1.3.6 Small for Gestational Age
        1.3.7 SHOX Deficiency
        1.3.8 Others
    1.4 EMEA Human Growth Hormone Market by Region
        1.4.1 EMEA Human Growth Hormone Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Human Growth Hormone (2012-2022)
        1.5.1 EMEA Human Growth Hormone Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Human Growth Hormone Revenue and Growth Rate (2012-2022)

2 EMEA Human Growth Hormone Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Human Growth Hormone Market Competition by Players/Manufacturers
        2.1.1 EMEA Human Growth Hormone Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Human Growth Hormone Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Human Growth Hormone Sale Price by Players (2012-2017)
    2.2 EMEA Human Growth Hormone (Volume and Value) by Type/Product Category
        2.2.1 EMEA Human Growth Hormone Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Human Growth Hormone Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Human Growth Hormone Sale Price by Type (2012-2017)
    2.3 EMEA Human Growth Hormone (Volume) by Application
    2.4 EMEA Human Growth Hormone (Volume and Value) by Region
        2.4.1 EMEA Human Growth Hormone Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Human Growth Hormone Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Human Growth Hormone Sales Price by Region (2012-2017)

3 Europe Human Growth Hormone (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Human Growth Hormone Sales and Value (2012-2017)
        3.1.1 Europe Human Growth Hormone Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Human Growth Hormone Revenue and Growth Rate (2012-2017)
    3.2 Europe Human Growth Hormone Sales and Market Share by Type
    3.3 Europe Human Growth Hormone Sales and Market Share by Application
    3.4 Europe Human Growth Hormone Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Human Growth Hormone Sales Volume by Countries (2012-2017)
        3.4.2 Europe Human Growth Hormone Revenue by Countries (2012-2017)
        3.4.3 Germany Human Growth Hormone Sales and Growth Rate (2012-2017)
        3.4.4 France Human Growth Hormone Sales and Growth Rate (2012-2017)
        3.4.5 UK Human Growth Hormone Sales and Growth Rate (2012-2017)
        3.4.6 Russia Human Growth Hormone Sales and Growth Rate (2012-2017)
        3.4.7 Italy Human Growth Hormone Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Human Growth Hormone Sales and Growth Rate (2012-2017)

4 Middle East Human Growth Hormone (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Human Growth Hormone Sales and Value (2012-2017)
        4.1.1 Middle East Human Growth Hormone Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Human Growth Hormone Revenue and Growth Rate (2012-2017)
    4.2 Middle East Human Growth Hormone Sales and Market Share by Type
    4.3 Middle East Human Growth Hormone Sales and Market Share by Application
    4.4 Middle East Human Growth Hormone Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Human Growth Hormone Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Human Growth Hormone Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Human Growth Hormone Sales and Growth Rate (2012-2017)
        4.4.4 Israel Human Growth Hormone Sales and Growth Rate (2012-2017)
        4.4.5 UAE Human Growth Hormone Sales and Growth Rate (2012-2017)
        4.4.6 Iran Human Growth Hormone Sales and Growth Rate (2012-2017)

5 Africa Human Growth Hormone (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Human Growth Hormone Sales and Value (2012-2017)
        5.1.1 Africa Human Growth Hormone Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Human Growth Hormone Revenue and Growth Rate (2012-2017)
    5.2 Africa Human Growth Hormone Sales and Market Share by Type
    5.3 Africa Human Growth Hormone Sales and Market Share by Application
    5.4 Africa Human Growth Hormone Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Human Growth Hormone Sales Volume by Countries (2012-2017)
        5.4.2 Africa Human Growth Hormone Revenue by Countries (2012-2017)
        5.4.3 South Africa Human Growth Hormone Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Human Growth Hormone Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Human Growth Hormone Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Human Growth Hormone Sales and Growth Rate (2012-2017)

6 EMEA Human Growth Hormone Manufacturers/Players Profiles and Sales Data
    6.1 Novo Nordisk
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Human Growth Hormone Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Novo Nordisk Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Human Growth Hormone Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Eli Lilly
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Human Growth Hormone Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eli Lilly Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Merck Serono
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Human Growth Hormone Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merck Serono Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 F. Hoffmann-La Roche
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Human Growth Hormone Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 F. Hoffmann-La Roche Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Ferring Pharmaceuticals
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Human Growth Hormone Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Ferring Pharmaceuticals Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 GeneScience Pharmaceuticals
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Human Growth Hormone Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 GeneScience Pharmaceuticals Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Ipsen
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Human Growth Hormone Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Ipsen Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 LG Life Sciences
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Human Growth Hormone Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 LG Life Sciences Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Sandoz International
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Human Growth Hormone Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Sandoz International Human Growth Hormone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Anhui Anke Biotechnology

7 Human Growth Hormone Manufacturing Cost Analysis
    7.1 Human Growth Hormone Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Human Growth Hormone

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Human Growth Hormone Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Human Growth Hormone Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Human Growth Hormone Market Forecast (2017-2022)
    11.1 EMEA Human Growth Hormone Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Human Growth Hormone Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Human Growth Hormone Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Human Growth Hormone Price and Trend Forecast (2017-2022)
    11.2 EMEA Human Growth Hormone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Human Growth Hormone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Human Growth Hormone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Human Growth Hormone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Human Growth Hormone Sales Forecast by Type (2017-2022)
    11.7 EMEA Human Growth Hormone Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer